Dear Editor:

This is a response to TarikSammour\'s letter concerning my manuscript "Improved outcomes for lap-banding using the Insuflow device compared with heated-only gas" 2009;13:302--305. Please thank them for their commendation of the double-blinded, randomized nature of the study. This study was double-blinded and randomized as described and created the only high-quality study regarding a comparison of traditional dry cool carbon dioxide gas to dry warm gas using the Stryker heated tube and humidified warmed gas using the Insu*flow*® device.

The insufflator was screened from the operator\'s view. The gas outlet connection was modified to adapt to the Insu*flow* device, which was either left dry for the traditional dry cool gas group or infused with 10cc of sterile saline for the humidified warmed group. The dry warm group utilized the Stryker heated-only tube. This was prepared out of view of the surgeon by a separate person prior to the surgeon\'s entry into the operating room and connected to all apparatus, regardless of allocation. A drape was placed over the connection from the insufflator to the end of the devices for each case. Trocar entry was done by the surgeon, and placement of the distal end of the tubing attached to a trocar was done by a surgical assistant.

Your article "Meta-analysis of the effect of warm humidified insufflation on pain after laparoscopy" concluded that there were seven (7) randomized controlled trials showing a significant reduction in pain scores and analgesic use. These 7 are in contradistinction to the "very few" you claim and list only 2 in your letter.

The inventor of the Insu*flow* device, Douglas E. Ott, MD, is a member of the *JSLS* Editorial Board not an Associate Editor. This situation in my opinion and apparently in the opinion of the Editor-in-Chief of *JSLS* is not a conflict or a reason for disclosure.

Since you feel so strongly about the need for disclosure, it is interesting that you submitted a study to [ClinicalTrials.gov](http://ClinicalTrials.gov) <http://clinicaltrial.gov/ct2/show/NCT00642005> "Humidification in laparoscopic colonic surgery" using the Fisher and Paykel Humidifier. Because this would be a competing device to the Insu*flow*, you should have mentioned this as a conflict of interest in your letter to the editor. It is further noted in this proposal "Research and Design Methods" that you did not disclose how you would accomplish blinding other than saying "operating surgeons and other members of the clinical team will be blinded to the treatment given."
